NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children

CompletedN/A

Sponsor: Sanofi Pasteur, a Sanofi Company

Conditions: Dengue, Dengue Fever, Dengue Hemorrhagic Fever

Countries: India

This is a descriptive prospective community-based seroprevalence study. Primary objective: * To determine the prevalence of specific antibodies (immunoglobulin G \[IgG\]) against dengue in healthy 5 to 10 year-old children in India. Secondary objectives: * To determine the dengue virus serotype (DeNV-1,2,3 and /or 4) specific to the antibodies in positive (IgG) samples * To estimate the prevalence of specific antibodies (IgG) against Japanese encephalitis in healthy 5 to 10 year-old children in India.

Eligibility overview

Sex: ALL

Age: 5 Years to 10 Years

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Aged between 5 and 10 year-old on the day of inclusion
* Healthy child as reported by the parent or legally qualified guardian
* Being registered in selected study site
* Provision of the informed consent form signed by at least one parent or legally qualified guardian
* For children between 8 and 10 years old, provision of the assent form signed.

Exclusion Criteria:

* N/A

Locations (4)

Kalyani, West Bengali, India
Bangalore, India
Hyderabad, India
New Delhi, India